Bosnia and Herzegovina vs Malawi: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bosnia and Herzegovina
0.3%
in 2024
Malawi
0.3%
in 2024
Bosnia and Herzegovina rank
85th
Malawi rank
85th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bosnia and Herzegovina
- Malawi
How they compare
Bosnia and Herzegovina currently reports 0.3% against 0.3% in Malawi, a difference of 0.0%.
Across all 10 years both countries report, Malawi has been ahead every year.
Bosnia and Herzegovina ranks 85th and Malawi ranks 85th of 246 countries.
Malawi has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bosnia and Herzegovina | Malawi | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.5% | 0.2% | Malawi |
| 2020s | 0.3% | 0.4% | 0.1% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bosnia and Herzegovina or Malawi?
- Bosnia and Herzegovina, at 0.3% against 0.3% in Malawi as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bosnia and Herzegovina and Malawi?
- 0.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and Malawi?
- 10 years are reported by both, from 2015 to 2024.
- How do Bosnia and Herzegovina and Malawi rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bosnia and Herzegovina ranks 85th and Malawi ranks 85th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.